News Updates
More Articles
- Industry Perspective on Singapore’s Rise as a Trusted Global Regulatory Leader
- Obesity Drug Development: Time to Revisit Endpoints, Trial Design, and Evidence Generation
- The Data Is Already There: Reimagining Site Source in Clinical Trials
- Beyond the Speed Gap: What Differentiates Chinese Local Companies and MNCs in Drug Development?
- Prioritizing and Delivering Prevention: Why Europe Cannot Afford to Wait
“Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
From emerging global trends in patient involvement in clinical trials, through redesigning the consent process, to creative solutions to real-world barriers, this article overviews several recent initiatives that aim to bring these possibilities into practice in the EU.